Pulmonary Function Testing The Basics of Interpretation

Similar documents
Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

Basic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic

PFT Interpretation and Reference Values

What do pulmonary function tests tell you?

PULMONARY FUNCTION TESTS

Pulmonary Function Testing

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

Pulmonary Function Testing. Ramez Sunna MD, FCCP

Chapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

Assessment of the Lung in Primary Care

Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology

Interpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow

Pulmonary Function Tests. Mohammad Babai M.D Occupational Medicine Specialist

Triennial Pulmonary Workshop 2012

PULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests

Objectives. Pulmonary Assessment 12/13/2017

A Primer on Reading Pulmonary Function Tests. Joshua Benditt, M.D.

S P I R O M E T R Y. Objectives. Objectives 3/12/2018

Pulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):

S P I R O M E T R Y. Objectives. Objectives 2/5/2019

Coexistence of confirmed obstruction in spirometry and restriction in body plethysmography, e.g.: COPD + pulmonary fibrosis

Content Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties

Chronic Cough. Abhishek Kumar, MD, MPH Pulmonary and Critical Care Mercy Medical Center, Cedar Rapids, IA

Pulmonary Func-on Tes-ng. Chapter 8

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

3 COPD Recognition and Diagnosis: Approach to the Patient with Respiratory Symptoms

Anyone who smokes and/or has shortness of breath and sputum production could have COPD

COPD. Breathing Made Easier

6- Lung Volumes and Pulmonary Function Tests

RESPIRATORY PHYSIOLOGY Pre-Lab Guide

COMPREHENSIVE RESPIROMETRY

Spirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.

Respiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician

The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE

Pulmonary Pathophysiology

#8 - Respiratory System

Referring for specialist respiratory input. Dr Melissa Heightman Consultant respiratory physician, UCLH,WH, CNWL

Lab 4: Respiratory Physiology and Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) Clinical Guideline

Spirometry and Interpretation of Spirometry

LUNG FUNCTION TESTING: SPIROMETRY AND MORE

Respiratory System Mechanics

Pulmonary Function Test

ARF, Mechaical Ventilation and PFTs: ACOI Board Review 2018

Pulmonary Function Testing

Office Spirometry Guide

Lung Volume Reduction Surgery. February 2013

Understanding the Basics of Spirometry It s not just about yelling blow

Pulmonary Test Brenda Shinar

WORKSHOP OF LUNG FUNCTION TEST. Dr. Lo Iek Long, Department of Respiratory Medicine, CHCSJ, Macau

Evaluating dyspnea: A practical approach -- When to consider cardiopulmonary exercise testing.

COPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum

RESPIRATORY EMERGENCIES. Michael Waters MD April 2004

Spirometry Workshop for Primary Care Nurse Practitioners

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

RESPIRATORY CARE IN GENERAL PRACTICE

Clinical pulmonary physiology. How to report lung function tests

Spirometry: an essential clinical measurement

Pulmonary-Vascular Disease. Howard J. Sachs, MD.

Maximal expiratory flow rates (MEFR) measured. Maximal Inspiratory Flow Rates in Patients With COPD*

Respiratory Physiology In-Lab Guide

Spirometry in primary care

The Aging Lung. Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI

Clinical Study Bronchial Responsiveness in Patients with Restrictive Spirometry

بسم هللا الرحمن الرحيم

Int. J. Pharm. Sci. Rev. Res., 34(2), September October 2015; Article No. 24, Pages: Role of Spirometry in Diagnosis of Respiratory Diseases

CLINICAL SIGNIFICANCE OF PULMONARY FUNCTION TESTS

Subject Index. Carbon monoxide (CO) disease effects on levels 197, 198 measurement in exhaled air 197 sources in exhaled air 197

Physiology lab (RS) First : Spirometry. ** Objectives :-

UNIVERSITY OF JORDAN DEPT. OF PHYSIOLOGY & BIOCHEMISTRY RESPIRATORY PHYSIOLOGY MEDICAL STUDENTS FALL 2014/2015 (lecture 1)

The role of Pulmonary function Testing In Interstitial lung disease in infants. [ ipft in child ]

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs

PULMONARY FUNCTION TEST(PFT)

Lung Pathophysiology & PFTs

Lecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)

Restrictive Pulmonary Diseases

Question by Question (QXQ) Instructions for the Pulmonary Diagnosis Form (PLD)

Overview of Obstructive Diseases of the Lung, Lung Physiology and Imaging Modalities

Spirometry: Introduction

Current Approaches to Asthma & COPD

Online Data Supplement. Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey

The objectives of the pre-anaesthetic assessment

i. Zone 1 = dead space ii. Zone 2 = ventilation = perfusion (ideal situation) iii. Zone 3 = shunt

SPIROMETRY. Marijke Currie (CRFS) Care Medical Ltd Phone: Copyright CARE Medical ltd

Essen%als of Spirometry and Assessment

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MOUSTAPHA ABIDALI, DO CRITICAL CARE FELLOW UNIVERSITY OF ARIZONA- PHOENIX

Known Allergies: Shellfish. Symptoms: abdominal pain, nausea, diarrhea, or vomiting. congestion, trouble breathing, or wheezing.

Office Based Spirometry

Preoperative Workup for Pulmonary Resection. Kristen Bridges, M.D. Richmond University Medical Center January 21, 2016

Utility of Lung Clearance Index (LCI) as a Noninvasive Marker of Deployment Lung Disease. Silpa Krefft, M.D., M.P.H. September 20, 2016

Over the last several years various national and

Variation in lung with normal, quiet breathing. Minimal lung volume (residual volume) at maximum deflation. Total lung capacity at maximum inflation

Chronic Obstructive Pulmonary Disease Guidelines and updates

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D.

Asthma in Children with Sickle Cell Disease

Chronic Obstructive Pulmonary Disease (COPD).

Chronic obstructive lung disease. Dr/Rehab F.Gwada

An Approach to Interpreting Spirometry

I LUNG FUNCTION ASSESSMENT AND THORACIC DIAGNOSTIC TECHNIQUES

PULMONARY FUNCTION. VOLUMES AND CAPACITIES

Transcription:

Pulmonary Function Testing The Basics of Interpretation Jennifer Hale, M.D. Valley Baptist Family Practice Residency

Objectives Identify the components of PFTs Describe the indications Develop a stepwise approach to interpretation Recognize common patterns Apply this information to patient care

Pulmonary Function Testing Jennifer Hale, M.D. Which of the following is used to follow disease severity in COPD patients? a. Total lung capacity (TLC) b. Degree of responsiveness to bronchodilators c. Forced vital capacity (FVC) d. Forced expiratory volume in 1 second e. Diffusing capacity (DLCO)

Pulmonary Function Testing Jennifer Hale, M.D. A 36yo WF, non-smoker, presents to your office for follow-up of recurrent bronchitis. You suspect asthma and decide to order spirometry. Which of the following would you include in your prescription for testing? a. Diffusing Capacity (DLCO) b. If no obstruction present, add trial of bronchodilator c. If no obstruction present, perform methacholine challenge d. Flow volume loop e. b and c

Pulmonary Function Testing Jennifer Hale, M.D. A 68yo HM is admitted to the ICU with acute respiratory distress. A CXR obtained in the ED demonstrates bilateral pulmonary infiltrates, and his DLCO is elevated. What is the most likely diagnosis? a. Pulmonary edema b. Aspiration pneumonitis c. Pulmonary emboli d. Alveolar hemorrhage e. Interstitial lung disease

The Purpose Provide quantifiable, reproducible measurement of lung function

Description Spirometry Flow Volume Loop Bronchodilator response Lung volumes Diffusion capacity (DLCO) Bronchoprovocation testing Maximum respiratory pressures Simple and complex cardiopulmonary exercise testing

Indications Diagnosis Evaluation of signs and symptoms - SOB, exertional dyspnea, chronic cough Screening at-risk populations Monitoring pulmonary drug toxicity Abnormal study - CXR, EKG, ABG, hemoglobin Preoperative assessment

Indications Diagnosis Evaluation of signs and symptoms - SOB, exertional dyspnea, chronic cough Screening at-risk populations Monitoring pulmonary drug toxicity Abnormal study - CXR, EKG, ABG, hemoglobin Preoperative assessment Smokers > 45yo (former & current)

Indications Diagnosis Evaluation of signs and symptoms - SOB, exertional dyspnea, chronic cough Screening at-risk populations Evaluation of occupational symptoms Monitoring pulmonary drug toxicity Abnormal study - CXR, EKG, ABG, hemoglobin Preoperative assessment

Indications Prognostic Assess severity Follow response to therapy Determine further treatment goals Referral for surgery Disability

Spirometry Simple, office-based Measures flow, volumes Volume vs. Time Can determine: - Forced expiratory volume in one second (FEV 1 ) - Forced vital capacity (FVC) - FEV 1 /FVC - Forced expiratory flow 25%-75% (FEF 25-75 )

Lung Volumes

Spirometry

Normal Spirometry

Obstructive Pattern Decreased FEV 1 Decreased FVC Decreased FEV 1 /FVC - <70% predicted FEV 1 used to follow severity in COPD

Obstructive Lung Disease Differential Diagnosis Asthma COPD - chronic bronchitis - emphysema Bronchiectasis Bronchiolitis Upper airway obstruction

Restrictive Pattern Decreased FEV 1 Decreased FVC FEV 1 /FVC normal or increased

Restrictive Lung Disease Differential Diagnosis Pleural Parenchymal Chest wall Neuromuscular

Spirometry Patterns

Bronchodilator Response Degree to which FEV 1 improves with inhaled bronchodilator Documents reversible airflow obstruction Significant response if: - FEV 1 increases by 12% and >200ml Request if obstructive pattern on spirometry

Flow Volume Loop Spirogram Measures forced inspiratory and expiratory flow rate Augments spirometry results Indications: evaluation of upper airway obstruction (stridor, unexplained dyspnea)

Flow Volume Loop

Upper Airway Obstruction Variable intrathoracic obstruction Variable extrathoracic obstruction Fixed obstruction

Upper Airway Obstruction

Lung Volumes Measurement: - helium - nitrogen washout - body plethsmography Indications: - Diagnose restrictive component - Differentiate chronic bronchitis from emphysema

Lung Volumes Patterns Obstructive - TLC > 120% predicted - RV > 120% predicted Restrictive - TLC < 80% predicted - RV < 80% predicted

Diffusing Capacity Diffusing capacity of lungs for CO Measures ability of lungs to transport inhaled gas from alveoli to pulmonary capillaries Depends on: - alveolar capillary membrane - hemoglobin concentration - cardiac output

Diffusing Capacity Decreased DLCO (<80% predicted) Obstructive lung disease Parenchymal disease Pulmonary vascular disease Anemia Increased DLCO (>120-140% predicted) Asthma (or normal) Pulmonary hemorrhage Polycythemia Left to right shunt

DLCO Indications Differentiate asthma from emphysema Evaluation and severity of restrictive lung disease Early stages of pulmonary hypertension Expensive!

Case 1 CC/HPI: A 36yo WM, nonsmoker, presents to your clinic with c/o episodic cough for 6mo. Also reports occasional wheezing and dyspnea with exertion during softball practice. Exam: Heart RRR, no murmurs; Lungs CTAB, no labored breathing Based on your exam and a thorough review of systems, you suspect asthma and decide to order spirometry for further evaluation.

Continued PFTs: FEV 1 FEV 1 /FVC 86% predicted 82% predicted Flow Volume Loop: normal inspiratory and expiratory pattern You still suspect asthma. What is your next step in the workup of this patient?

Bronchoprovocation Useful for diagnosis of asthma in the setting of normal pulmonary function tests Common agents: - Methacholine, Histamine, others Diagnostic if: 20% decrease in FEV 1

Continued YES TREAT SYMPTOMS PFTs OBSTRUCTION? NO BRONCHOPROVOCATION Obstruction? No Obstruction? TREAT Other Diagnosis

PFT Interpretation Strategy What is the clinical question? What is normal? Did the test meet American Thoracic Society (ATS) criteria? Don t forget (or ignore) the flow volume loop!

Obstructive Pattern Evaluation Spirometry FEV 1, FVC: FEV 1 /FVC: decreased decreased (<70% predicted) FV Loop scooped Lung Volumes TLC, RV: increased Bronchodilator responsiveness

Restrictive Pattern Evaluation Spirometry FVC, FEV 1 : FEV 1 /FVC: FV Loop DLCO Lung Volumes TLC, RV: decreased normal or increased witch s hat decreased decreased Muscle pressures may be important

PFT Patterns Emphysema FEV 1 /FVC <70% Scooped FV curve TLC increased Increased compliance DLCO decreased Chronic Bronchitis FEV 1 /FVC <70% Scooped FV curve TLC normal Normal compliance DLCO usually normal

PFT Patterns Asthma FEV 1 /FVC normal or decreased DLCO normal or increased But PFTs may be normal bronchoprovocation

Pulmonary Function Testing Jennifer Hale, M.D. Which of the following is used to follow disease severity in COPD patients? a. Total lung capacity (TLC) b. Degree of responsiveness to bronchodilators c. Forced vital capacity (FVC) d. Forced expiratory volume in 1 second e. Diffusing capacity (DLCO)

Pulmonary Function Testing Jennifer Hale, M.D. Which of the following is used to follow disease severity in COPD patients? a. Total lung capacity (TLC) b. Degree of responsiveness to bronchodilators c. Forced vital capacity (FVC) d. Forced expiratory volume in 1 second e. Diffusing capacity (DLCO)

Pulmonary Function Testing Jennifer Hale, M.D. A 36yo WF, non-smoker, presents to your office for follow-up of recurrent bronchitis. You suspect asthma and decide to order spirometry. Which of the following would you include in your prescription for testing? a. Diffusing Capacity (DLCO) b. If no obstruction present, add trial of bronchodilator c. If no obstruction present, perform methacholine challenge d. Flow volume loop e. b and c

Pulmonary Function Testing Jennifer Hale, M.D. A 36yo WF, non-smoker, presents to your office for follow-up of recurrent bronchitis. You suspect asthma and decide to order spirometry. Which of the following would you include in your prescription for testing? a. Diffusing Capacity (DLCO) b. If no obstruction present, add trial of bronchodilator c. If no obstruction present, perform methacholine challenge d. Flow volume loop e. b and c

Pulmonary Function Testing Jennifer Hale, M.D. A 68yo HM is admitted to the ICU with acute respiratory distress. A CXR obtained in the ED demonstrates bilateral pulmonary infiltrates, and his DLCO is elevated. What is the most likely diagnosis? a. Pulmonary edema b. Aspiration pneumonitis c. Pulmonary emboli d. Alveolar hemorrhage e. Interstitial lung disease

Pulmonary Function Testing Jennifer Hale, M.D. A 68yo HM is admitted to the ICU with acute respiratory distress. A CXR obtained in the ED demonstrates bilateral pulmonary infiltrates, and his DLCO is elevated. What is the most likely diagnosis? a. Pulmonary edema b. Aspiration pneumonitis c. Pulmonary emboli d. Alveolar hemorrhage e. Interstitial lung disease

Questions?

References 1. Aboussouan LS, Stoller JK: Flow volume loops. UpToDate, 2006. 2. Bahhady IJ, Unterborn J: Pulmonary function tests: an update. Consultant. 2003. 3. Barreiro, TJ, Perillo I: An approach to interpreting spirometry. Am Fam Physician. 2004 Mar 1;69(5):1107-14. 4. Chesnutt MS, Prendergast TJ. Current Medical Diagnosis and Treatment. New York: Appleton and Lange, 2006. 5. Enright PL: Diffusing capacity for carbon monoxide. UpToDate, 2007. 6. Enright PL: Overview of pulmonary function testing in adults. UpToDate, 2007. 7. Irvin CG: Bronchoprovocation testing. UpToDate, 2006. 8. West JB. Respiratory Physiology: The Essentials. Lippincot Williams & Wilkins, 2000.